BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1951842)

  • 1. Immunoreactivity for estrogen receptor protein in sweat gland tumors.
    Swanson PE; Mazoujian G; Mills SE; Campbell RJ; Wick MR
    Am J Surg Pathol; 1991 Sep; 15(9):835-41. PubMed ID: 1951842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
    Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
    J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas.
    Busam KJ; Tan LK; Granter SR; Kohler S; Junkins-Hopkins J; Berwick M; Rosen PP
    Mod Pathol; 1999 Aug; 12(8):786-93. PubMed ID: 10463481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical studies of normal sweat glands, sweat gland tumors and extramammary Paget's diseases. II. Immunohistochemical studies of sweat gland tumors and extramammary Paget's diseases].
    Ansai S
    Nihon Hifuka Gakkai Zasshi; 1990 Feb; 100(2):133-46. PubMed ID: 2165191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroid hormone receptors in human skin appendage and its neoplasms.
    Kariya Y; Moriya T; Suzuki T; Chiba M; Ishida K; Takeyama J; Endoh M; Watanabe M; Sasano H
    Endocr J; 2005 Jun; 52(3):317-25. PubMed ID: 16006726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of CD23 in cutaneous non-lymphoid neoplasms.
    Carvalho J; Fullen D; Lowe L; Su L; Ma L
    J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistological Expression of p16INK4a is Commonly Present Both in Benign and Malignant Sweat Gland Neoplasias.
    Tsujita J; Kaku Y; Ichiki T; Eto A; Maemura H; Otsuka A; Nakaie R; Kitagawa N; Morioka Y; Matsuda T; Yoshida M; Furue M
    Fukuoka Igaku Zasshi; 2015 Dec; 106(12):323-9. PubMed ID: 27159948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical demonstration of myoepithelial cells in sweat gland carcinomas.
    Wach F; Hein R; Kuhn A; Landthaler M; Krieg T; Eckert F
    Br J Dermatol; 1994 Apr; 130(4):432-7. PubMed ID: 8186107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
    Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
    Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perilipin and adipophilin expression in sebaceous carcinoma and mimics.
    Boussahmain C; Mochel MC; Hoang MP
    Hum Pathol; 2013 Sep; 44(9):1811-6. PubMed ID: 23642680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Her-2 expression in cutaneous eccrine and apocrine neoplasms.
    Hiatt KM; Pillow JL; Smoller BR
    Mod Pathol; 2004 Jan; 17(1):28-32. PubMed ID: 14631375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.
    Rollins-Raval M; Chivukula M; Tseng GC; Jukic D; Dabbs DJ
    Arch Pathol Lab Med; 2011 Aug; 135(8):975-83. PubMed ID: 21809988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DF3 (CA15-3) antibody as a marker of cutaneous adnexal tumors.
    Yasui S; Ando I; Kukita A; Hino H; Ohara K
    Acta Derm Venereol; 1994 Mar; 74(2):98-100. PubMed ID: 7911637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
    Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
    Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical demonstration of breast-derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors.
    Tsubura A; Senzaki H; Sasaki M; Hilgers J; Morii S
    J Cutan Pathol; 1992 Feb; 19(1):73-9. PubMed ID: 1556271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma: can it always be accomplished reliably?
    Mentrikoski MJ; Wick MR
    Am J Clin Pathol; 2015 Mar; 143(3):430-6. PubMed ID: 25696802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 expression in sweat gland tumors.
    Biernat W; Woźniak L
    Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study of BCA-225 in various skin cancers.
    Ansai S; Hozumi Y; Kondo S
    J Dermatol; 1994 Jan; 21(1):20-4. PubMed ID: 8157817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
    Iijima M; Nakayama J; Nishizawa T; Ishida A; Ishii K; Ota H; Katsuyama T; Saida T
    Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.